Bleakley Financial Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bleakley Financial Group’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell
2024 Q4	$330K	Buy
2024 Q3	–	Sell
2024 Q2	$210K	Sell
2024 Q1	$258K	Sell
2023 Q4	$295K	Buy
2023 Q3	$263K	Buy
2023 Q2	$238K	Buy
2023 Q1	$259K	Sell
2022 Q4	$1.63M	Buy